Virica Biotech

We pioneered a new product category of Viral Sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. Customized VSE formulations optimize research processes and enhance production. Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Recent influenza outbreaks and the COVID-19 pandemic highlight the need for scalability in the production of vaccines. Virica has the products and experience to combat these challenges. Here is a snapshot of organizations with whom we share knowledge by attending meetings or giving presentations. Virica is a member of BIOTECanada, an association building a climate for biotechnology firms to succeed in today’s hyper-competitive economy. Virica is a member of Alliance of Regenerative Medicine.